Skye Bioscience (SKYE) Non Operating Interest Expenses (2013 - 2026)
Skye Bioscience's Non Operating Interest Expenses came in at $3,299 for Q2 2026, up 50.0% from the prior quarter.
Powered by 
Analysis
Skye Bioscience (SKYE) Non Operating Interest Expenses (2013 - 2026) Analysis & Trends
Over the trailing twelve months to Jun 30, 2026, Skye Bioscience reported Non Operating Interest Expenses of $5,498; for FY2024, it was $749,308, down 17.3% from FY2023.
- Non Operating Interest Expenses carries a five-year compound annual growth rate of -5.6% (FY2019 to FY2024).
- Going back by year, Non Operating Interest Expenses was $906,270 in FY2023 (+36.3%), $665,133 in FY2022 (-13.5%), $769,159 in FY2021 (+8.9%) and $706,385 in FY2020 (-29.4%).
- The Q2 2026 figure represents the highest quarterly Non Operating Interest Expenses since Q2 2024.
- The fastest year-over-year change in Non Operating Interest Expenses over five years came in Q4 2023 (growth of 767.7%), and the weakest in Q1 2025 (a decline of 99.7%).
Peer Set
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | Non Operating Interest Expenses (Qtr) |
|---|---|---|---|---|---|
| 1 | Johnson & Johnson | 638.12 Bn | 556.64 Bn | 17.26 Bn | 281.00 Mn |
| 2 | AbbVie | 462.60 Bn | 435.75 Bn | 12.70 Bn | - |
| 3 | Merck | 358.70 Bn | 313.13 Bn | 12.21 Bn | - |
| 4 | Novartis Ag | 272.16 Bn | 228.03 Bn | 11.24 Bn | -462.00 Mn |
| 5 | Astrazeneca | 250.36 Bn | 223.92 Bn | 12.86 Bn | -435.00 Mn |
| 6 | Amgen | 227.87 Bn | 183.27 Bn | 7.24 Bn | 673.00 Mn |
| 7 | Gilead Sciences | 184.97 Bn | 159.08 Bn | 6.22 Bn | 247.00 Mn |
| 8 | Pfizer | 162.61 Bn | 109.56 Bn | 10.94 Bn | - |
| 9 | Vertex Pharmaceuticals | 132.45 Bn | 104.46 Bn | 2.84 Bn | - |
| 10 | Skye Bioscience | 7.07 Mn | 7.07 Mn | - | 3,299.00 |
Historic Data
Download Data
Historic Data
| Date | Value |
|---|---|
| Jun 30, 2026 | 3,299.00 |
| Mar 31, 2026 | 2,199.00 |
| Mar 31, 2025 | 1,452.00 |
| Dec 31, 2024 | -46,914.00 |
| Sep 30, 2024 | -90,766.00 |
| Jun 30, 2024 | 450,052.00 |
| Mar 31, 2024 | 436,936.00 |
| Dec 31, 2023 | 430,135.00 |
| Sep 30, 2023 | 271,307.00 |
| Jun 30, 2023 | 186,429.00 |
| Mar 31, 2023 | 18,396.00 |
| Dec 31, 2022 | 49,570.00 |
| Sep 30, 2022 | 211,229.00 |
| Jun 30, 2022 | 205,300.00 |
| Mar 31, 2022 | 199,033.00 |
| Dec 31, 2021 | 198,837.00 |
| Sep 30, 2021 | 195,358.00 |
| Jun 30, 2021 | 190,058.00 |
| Mar 31, 2021 | 184,905.00 |
| Dec 31, 2020 | 185,791.00 |
API Access
Skye Bioscience Non Operating Interest Expenses API
Pull this series into your own models, spreadsheets and apps with the Business Quant
Historical Metrics API. The request below matches the chart above — change the
frequency, period or values and it follows. Swap YOUR_API_KEY for your own key.
https://data.businessquant.com/historic?slug=non-operating-interest-expenses&ticker=SKYE&period=max&api_key=YOUR_API_KEYimport requests
url = "https://data.businessquant.com/historic"
params = {"slug": "non-operating-interest-expenses", "ticker": "SKYE", "period": "max", "api_key": "YOUR_API_KEY"}
data = requests.get(url, params=params).json()const res = await fetch("https://data.businessquant.com/historic?slug=non-operating-interest-expenses&ticker=SKYE&period=max&api_key=YOUR_API_KEY");
const data = await res.json();